Craig-Hallum analyst Alex Fuhrman maintained a Buy rating on LifeMD (LFMD – Research Report) today. The company’s shares closed last Friday at ...
LifeMD (NASDAQ:LFMD) is scheduled to announce Q4 earnings results on Monday, March 10th, after market close. The consensus EPS Estimate is $0.14 (-6.7% Y/Y) and the consensus Revenue Estimate is ...
The "U.S. Medical Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering. This report presents a complete picture of the medical weight loss market in the ...